390 related articles for article (PubMed ID: 34145459)
21. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
[TBL] [Abstract][Full Text] [Related]
22. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
Front Immunol; 2021; 12():598778. PubMed ID: 33717077
[TBL] [Abstract][Full Text] [Related]
23. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
Lee CH; Pinho MP; Buckley PR; Woodhouse IB; Ogg G; Simmons A; Napolitani G; Koohy H
Front Immunol; 2020; 11():579480. PubMed ID: 33250893
[TBL] [Abstract][Full Text] [Related]
24. Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2.
Martín-Galiano AJ; López D
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892276
[TBL] [Abstract][Full Text] [Related]
25. Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.
Piadel K; Haybatollahi A; Dalgleish AG; Smith PL
J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35014605
[TBL] [Abstract][Full Text] [Related]
26. PopCover-2.0. Improved Selection of Peptide Sets With Optimal HLA and Pathogen Diversity Coverage.
Nilsson JB; Grifoni A; Tarke A; Sette A; Nielsen M
Front Immunol; 2021; 12():728936. PubMed ID: 34484239
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
[TBL] [Abstract][Full Text] [Related]
28. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
[TBL] [Abstract][Full Text] [Related]
29. BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity.
Eggenhuizen PJ; Ng BH; Chang J; Fell AL; Cheong RMY; Wong WY; Gan PY; Holdsworth SR; Ooi JD
Front Immunol; 2021; 12():692729. PubMed ID: 34421902
[TBL] [Abstract][Full Text] [Related]
30. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
Front Immunol; 2021; 12():627568. PubMed ID: 33995351
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
Pan K; Chiu Y; Huang E; Chen M; Wang J; Lai I; Singh S; Shaw RM; MacCoss MJ; Yee C
Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34725257
[TBL] [Abstract][Full Text] [Related]
33. Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein.
Zhang Y; Yang Z; Tang M; Li H; Tang T; Li G; Zhong Y; Zhang X; Wang X; Wang C
Front Immunol; 2022; 13():752622. PubMed ID: 35154095
[TBL] [Abstract][Full Text] [Related]
34. Identification of promising CD8 and CD4 T cell epitopes for peptide vaccine formulation against SARS-CoV-2.
Chakraborty S; Deb B; Nath D; Monoswita D
Arch Microbiol; 2022 Apr; 204(5):242. PubMed ID: 35380253
[TBL] [Abstract][Full Text] [Related]
35. Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an
Kesarwani V; Gupta R; Vetukuri RR; Kushwaha SK; Gandhi S
Front Immunol; 2021; 12():725240. PubMed ID: 34630400
[TBL] [Abstract][Full Text] [Related]
36. Genome-Wide B Cell, CD4
Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
J Immunol; 2021 Jun; 206(11):2566-2582. PubMed ID: 33911008
[TBL] [Abstract][Full Text] [Related]
37. HLA-A
Nesterenko PA; McLaughlin J; Tsai BL; Burton Sojo G; Cheng D; Zhao D; Mao Z; Bangayan NJ; Obusan MB; Su Y; Ng RH; Chour W; Xie J; Li YR; Lee D; Noguchi M; Carmona C; Phillips JW; Kim JT; Yang L; Heath JR; Boutros PC; Witte ON
Cell Rep; 2021 Dec; 37(13):110167. PubMed ID: 34919800
[TBL] [Abstract][Full Text] [Related]
38. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
Alam A; Khan A; Imam N; Siddiqui MF; Waseem M; Malik MZ; Ishrat R
Brief Bioinform; 2021 Mar; 22(2):1309-1323. PubMed ID: 33285567
[TBL] [Abstract][Full Text] [Related]
39. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
Chauhan V; Rungta T; Rawat M; Goyal K; Gupta Y; Singh MP
J Cell Physiol; 2021 Feb; 236(2):1131-1147. PubMed ID: 32643158
[TBL] [Abstract][Full Text] [Related]
40. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage.
Shukla P; Pandey P; Prasad B; Robinson T; Purohit R; D'Cruz LG; Tambuwala MM; Mutreja A; Harkin J; Rai TS; Murray EK; Gibson DS; Bjourson AJ
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34962259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
